| Literature DB >> 27924264 |
Nobuyuki Uchikoga1, Yuri Matsuzaki2, Masahito Ohue3, Yutaka Akiyama4.
Abstract
Analysis of protein-protein interaction networks has revealed the presence of proteins with multiple interaction ligand proteins, such as hub proteins. For such proteins, multiple ligands would be predicted as interacting partners when predicting all-to-all protein-protein interactions (PPIs). In this work, to obtain a better understanding of PPI mechanisms, we focused on protein interaction surfaces, which differ between protein pairs. We then performed rigid-body docking to obtain information of interfaces of a set of decoy structures, which include many possible interaction surfaces between a certain protein pair. Then, we investigated the specificity of sets of decoy interactions between true binding partners in each case of alpha-chymotrypsin, actin, and cyclin-dependent kinase 2 as test proteins having multiple true binding partners. To observe differences in interaction surfaces of docking decoys, we introduced broad interaction profiles (BIPs), generated by assembling interaction profiles of decoys for each protein pair. After cluster analysis, the specificity of BIPs of true binding partners was observed for each receptor. We used two types of BIPs: those involved in amino acid sequences (BIP-seqs) and those involved in the compositions of interacting amino acid residue pairs (BIP-AAs). The specificity of a BIP was defined as the number of group members including all true binding partners. We found that BIP-AA cases were more specific than BIP-seq cases. These results indicated that the composition of interacting amino acid residue pairs was sufficient for determining the properties of protein interaction surfaces.Entities:
Keywords: hub protein; interaction profile; postdocking process; protein-protein interaction; rigid-body docking process
Year: 2016 PMID: 27924264 PMCID: PMC5042157 DOI: 10.2142/biophysico.13.0_105
Source DB: PubMed Journal: Biophys Physicobiol ISSN: 2189-4779
List of proteins used in docking processes. Parentheses indicate PDBIDs of unbound states
| Docking receptors | True partner proteins | Receptors in crystal structures | ||
|---|---|---|---|---|
|
|
| |||
| Names | PDB IDs | Names | PDB IDs | |
| Alpha-chymotrypsin | 1ACB (2CGA) | eglin C | 1ACB (1EGL) | Alpha-chymotrypsin |
| PSTI | 1CGI (1HPT) | Alpha-chymotrypsinogen | ||
| BPTI | 1EAW (9PTI) | Matriptase | ||
|
| ||||
| Actin | 1ATN (1IJJ) | DNase I | 1ATN (3DNI) | Actin |
| Gelsolin | 1H1V (1D0N) | |||
| DBP | 1KXP (1KW2) | |||
|
| ||||
| CDK2 | 1BUH (1HCL) | CKSHS1 | 1BUH (1DKS) | CDK2 |
| CDKN3 | 1FQ1 (1FPZ) | |||
pancreatic secretory trypsin inhibitor,
pancreatic trypsin inhibitor,
human vitamin-D binding protein,
cyclin-dependent kinase 2,
cyclin-dependent kinase inhibitor 3,
names of receptors in X-ray crystal structure data with each true partner
Figure 1Flowchart for generating BIPs. After generating 2000 decoys by the rigid-body docking process with MEGADOCK, their tertiary structures were converted to interaction profiles with a reranking process. Broad interaction profiles (BIPs) were generated by assembling certain numbers (N-values) of profiles.
Figure 2Tree diagrams from cluster analysis by BIP similarities as Tanimoto distances. Each square includes all true partners. M-values are the numbers of ligands included in each square with minimum threshold T-values. The true partners with the quaternary structure of the bound state and the corresponding unbound state protein of PDBIDs are marked as “o_”. The other true partners are marked as “x_”.
List of the number of ligands in a classified group including all true partners (M-values)
| Tanimoto Distance | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Receptor protein | Bound state | Unbound state | |||||||
|
|
| ||||||||
|
|
| ||||||||
| 100 | 500 | 1,000 | 2,000 | 100 | 500 | 1,000 | 2,000 | ||
| Alpha-chymotrypsin | BIP-seq | 5 | 20 | 17 | 43 | 41 | 42 | 43 | 34 |
| BIP-AA | 20 | 8 | 12 | 11 | 22 | 26 | 9 | 7 | |
|
| |||||||||
| Actin | BIP-seq | 41 | 40 | 39 | 28 | 44 | 23 | 16 | 16 |
| BIP-AA | 41 | 21 | 14 | 12 | 25 | 27 | 21 | 13 | |
|
| |||||||||
| CDK2 | BIP-seq | 41 | 16 | 32 | 43 | 44 | 44 | 44 | 43 |
| BIP-AA | 43 | 25 | 43 | 39 | 15 | 43 | 43 | 43 | |
|
| |||||||||
| Euclidean Distance | |||||||||
|
| |||||||||
| Alpha-chymotrypsin | BIP-seq | 6 | 16 | 35 | 14 | 44 | 12 | 6 | 19 |
| BIP-AA | 22 | 24 | 20 | 10 | 25 | 15 | 5 | 8 | |
|
| |||||||||
| Actin | BIP-seq | 44 | 44 | 42 | 41 | 25 | 12 | 13 | 15 |
| BIP-AA | 41 | 22 | 23 | 12 | 17 | 43 | 10 | 13 | |
|
| |||||||||
| CDK2 | BIP-seq | 41 | 14 | 15 | 42 | 43 | 43 | 43 | 43 |
| BIP-AA | 40 | 43 | 39 | 39 | 40 | 33 | 40 | 38 | |
Physicochemical properties of the bound state
| PDBID | Net charge | Hydrophobicity | Number of interacting residue pairs | ||||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| Receptor | Ligand | Receptor | Ligand | Receptor | Ligand | ||
| 1ACB | 1ACB | 100 | 82 | 320 | 392 | −1428 | 3111 |
| 1CGI | 250 | −23 | 365.4 | −3708.9 | 2935 | ||
| 1EAW | 105 | 794 | 137.7 | −2664.8 | 2765 | ||
|
| |||||||
| 1ACB | 500 | 478 | 1566 | −139.2 | −9223.6 | 14692 | |
| 1CGI | 1012 | 4 | −1556.8 | −17940.2 | 13539 | ||
| 1EAW | 420 | 3786 | −2240.4 | −14204.09 | 13323 | ||
|
| |||||||
| 1ACB | 1000 | 1062 | 2970 | −5023.4 | −18962.71 | 28487 | |
| 1CGI | 1803 | 0 | −7359 | −37655.49 | 26563 | ||
| 1EAW | 886 | 7247 | −8434.5 | −29224.91 | 26576 | ||
|
| |||||||
| 1ACB | 2000 | 2392 | 5668 | −21928.2 | −41395.51 | 55915 | |
| 1CGI | 3022 | 195 | −24285.7 | −78172.12 | 52376 | ||
| 1EAW | 2136 | 14199 | −26546.41 | −60223.99 | 53624 | ||
|
| |||||||
| 1ATN | 1ATN | 100 | 219 | 139 | −4507.6 | −3973.2 | 3743 |
| 1H1V | 109 | 121 | −4634.1 | −4588 | 3864 | ||
| 1KXP | 3 | −1 | −4614.3 | −2721.1 | 4255 | ||
|
| |||||||
| 1ATN | 500 | 387 | 894 | −25735.1 | −21367.5 | 18486 | |
| 1H1V | 202 | 798 | −23722.7 | −21893.59 | 18350 | ||
| 1KXP | −33 | −4 | −23312.5 | −22638.71 | 19491 | ||
|
| |||||||
| 1ATN | 1000 | 582 | 2058 | −52365.68 | −45610.88 | 36613 | |
| 1H1V | 71 | 1451 | −51153.1 | −44999.39 | 36763 | ||
| 1KXP | −159 | 22 | −50730.7 | −49853.99 | 39312 | ||
|
| |||||||
| 1ATN | 2000 | 230 | 4587 | −113680.8 | −97211.3 | 75000 | |
| 1H1V | −709 | 2824 | −108758.3 | −96134.17 | 74603 | ||
| 1KXP | −1028 | −130 | −112267.11 | −111733.74 | 80426 | ||
|
| |||||||
| 1BUH | 1BUH | 100 | 377 | −221 | −3076.9 | −4293 | 2843 |
| 1FQ1 | 398 | 325 | −4381.1 | −3722.9 | 3375 | ||
|
| |||||||
| 1BUH | 500 | 1924 | −701 | −16989.3 | −19486.2 | 13554 | |
| 1FQ1 | 2306 | 1489 | −23405.9 | −19446.6 | 16929 | ||
|
| |||||||
| 1BUH | 1000 | 3778 | −838 | −34932 | −37541.2 | 26969 | |
| 1FQ1 | 4434 | 3003 | −47284.79 | −39759.89 | 34296 | ||
|
| |||||||
| 1BUH | 2000 | 7430 | −703 | −74073.6 | −76021.42 | 54585 | |
| 1FQ1 | 9194 | 6874 | −100196.3 | −83359.69 | 70848 | ||
Physicochemical properties of the unbound state
| PDBID | Net charge | Hydrophobicity | Number of interacting residue pairs | ||||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| Receptor | Ligand | Receptor | Ligand | Receptor | Ligand | ||
| 1ACB | 1ACB | 100 | 58 | −5 | −204.5 | −2073.2 | 2052 |
| 1CGI | 81 | 273 | −162.3 | −4592.4 | 2126 | ||
| 1EAW | 61 | 674 | −366.9 | −3512.1 | 2087 | ||
|
| |||||||
| 1ACB | 500 | 321 | −120 | −2411.8 | −10528.2 | 9534 | |
| 1CGI | 387 | 977 | −617.5 | −19018.4 | 9720 | ||
| 1EAW | 241 | 2916 | −2067.9 | −14417.5 | 9673 | ||
|
| |||||||
| 1ACB | 1000 | 676 | −289 | −5191.5 | −19787.2 | 18498 | |
| 1CGI | 700 | 1669 | −2326.6 | −35923.51 | 18394 | ||
| 1EAW | 511 | 5334 | −4467.3 | −26688.4 | 18413 | ||
|
| |||||||
| 1ACB | 2000 | 1300 | −598 | −10210 | −36639.5 | 35574 | |
| 1CGI | 1427 | 2502 | −6335 | −66801.51 | 34904 | ||
| 1EAW | 1101 | 9754 | −9848.8 | −49854.51 | 35037 | ||
|
| |||||||
| 1ATN | 1ATN | 100 | −120 | 333 | −3963 | −4298.8 | 3291 |
| 1H1V | −164 | 53 | −5074.8 | −5474.2 | 3613 | ||
| 1KXP | −199 | −42 | −4733.2 | −5231.8 | 3579 | ||
|
| |||||||
| 1ATN | 500 | −566 | 1437 | −18381.8 | −19863.8 | 14534 | |
| 1H1V | −711 | −173 | −20845.99 | −25009.81 | 16389 | ||
| 1KXP | −665 | −496 | −20928.3 | −26045.5 | 15840 | ||
|
| |||||||
| 1ATN | 1000 | −1173 | 2545 | −36763.21 | −39000.9 | 27991 | |
| 1H1V | −1481 | −142 | −40160.8 | −47217.21 | 31144 | ||
| 1KXP | −1220 | −1088 | −38860.49 | −50446.61 | 30127 | ||
|
| |||||||
| 1ATN | 2000 | −2468 | 4780 | −70724.91 | −74852.81 | 53554 | |
| 1H1V | −3070 | −194 | −77328.7 | −89695.49 | 59364 | ||
| 1KXP | −2573 | −2230 | −75127.91 | −97115.8 | 57889 | ||
|
| |||||||
| 1BUH | 1BUH | 100 | 479 | 161 | −3238.3 | −3294 | 2361 |
| 1FQ1 | 308 | 365 | −3496.7 | −3946 | 2782 | ||
|
| |||||||
| 1BUH | 500 | 1795 | 722 | −13457.1 | −17625.7 | 10622 | |
| 1FQ1 | 1485 | 1516 | −14542.7 | −18653.81 | 12177 | ||
|
| |||||||
| 1BUH | 1000 | 3128 | 1254 | −24678.2 | −34111.51 | 19918 | |
| 1FQ1 | 2885 | 2905 | −28007.2 | −36008.7 | 23171 | ||
|
| |||||||
| 1BUH | 2000 | 5802 | 2160 | −46804.9 | −65434.8 | 37755 | |
| 1FQ1 | 5221 | 5405 | −52693.5 | −66785.11 | 43747 | ||
Figure 3Alignment of receptors and interaction sites with x-ray crystal complex structures. Each receptor indicates PDBIDs corresponding to receptors in Table 1. Squares are interaction sites extracted from complex structure data by LIGPLOT [25].